Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Acute toxicity: oral. Supporting study: Based on the available data the oral LD50 for betahistine was determined to be 2920 mg/kg in mouse.

Acute toxicity: oral. Supporting study: Based on the available data the oral LD50 for betahistine was determined to be 6110 mg/kg in rat.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Referenceopen allclose all

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
secondary literature
Remarks:
No data on method, no data on GLP.
Principles of method if other than guideline:
No data on method
GLP compliance:
not specified
Species:
mouse
Strain:
not specified
Sex:
not specified
Route of administration:
oral: unspecified
Vehicle:
not specified
Control animals:
not specified
Key result
Sex:
not specified
Dose descriptor:
LD50
Effect level:
2 920 mg/kg bw
Based on:
test mat.
Mortality:
No data available.
Clinical signs:
No data available.
Body weight:
No data available.
Gross pathology:
No data available.
Interpretation of results:
GHS criteria not met
Conclusions:
The oral LD50 in mouse is 2920 mg/kg.
Executive summary:

The acute oral toxicity of the test substance was evaluated on mice. According to the results, the oral LD50 is 2920 mg/kg body weight.

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
secondary literature
Remarks:
No data on method, no data on GLP.
Principles of method if other than guideline:
No data on method
GLP compliance:
not specified
Species:
rat
Strain:
not specified
Sex:
not specified
Route of administration:
oral: unspecified
Vehicle:
not specified
Control animals:
not specified
Key result
Sex:
not specified
Dose descriptor:
LD50
Effect level:
6 110 mg/kg bw
Based on:
test mat.
Mortality:
No data available.
Clinical signs:
No data available.
Body weight:
No data available.
Gross pathology:
No data available.
Interpretation of results:
GHS criteria not met
Conclusions:
The oral LD50 in rats is 6110 mg/kg.
Executive summary:

The acute oral toxicity of the test substance was evaluated on rats. According to the results, the oral LD50 is 6110 mg/kg body weight.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
2 920 mg/kg bw
Quality of whole database:
Diverse oral LD50 are reported from a secondary source. The results of the whole database lead to the same classification of the substance according to CLP regulation.

Additional information

Acute toxicity: oral. Supporting study. The acute oral toxicity of the test substance was evaluated on mice. GLP study not specified. According to the results, the oral LD50 is 2920 mg/kg body weight.

Acute toxicity: oral. Supporting study. The acute oral toxicity of the test substance was evaluated on rats. GLP study not specified. According to the results, the oral LD50 is 6110 mg/kg body weight.

Justification for classification or non-classification

Based on the available data the oral LD50 was determined to be 2920 mg/kg in mouse. Betahistine has not to be classified for Acute oral toxicity according to CLP Regulation (EC) no. 1272/2008.